Total Funding
95
91
Total FundingPost-IPO Equity raised
Growth Score 95 in past quarter
6 pts
Heat Score 91 in past quarter
28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
60004
Hyundai Bioscience is a biotechnology company that develops drugs.
About the Company
Hyundai Bioscience develops methods for putting drugs into the body via drug delivery technology. Their organic-inorganic hybrid technologies, a patented technique, are a drug delivery system that makes use of inorganic compounds as drug carriers to enable the transport of bioactive molecules, such as low-molecular compounds, genes, or medicinal
medicines, to target areas. Chemical anti-cancer medications are given polymer carrier technology to reduce toxicity and curb adverse effects.